Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$790.16M-5,284%-$5.73M+75.9%$2.91M+120%-$5.86M+76.2%-$14.68M+41.9%
$6.87M+13.6%$6.07M+0.3%$6.06M+0.1%$6.06M+3.5%$6.05M+6.9%
$36.2M+129%$19.03M+43.6%$18.13M+52.2%$18.47M+56.0%$15.8M+38.0%
-$228.76M-11,566%$6.07M$39.68M+896%$12.04M-$1.96M-113%
$664K+1,520%$600K+2,900%$187K+3.3%$126K-83.8%$41K+215%
-$11.57M+28.3%$0-$2.23M+87.7%-$6.6M+90.9%-$16.13M-124,008%
$270.08M+4,147%$9M+68.5%$16.1M+317%$8.69M+19.2%$6.36M+428%
$28.48M+367%$15.66M+3,461%$53.9M+634%$16.36M+124%-$10.68M-165%
-$229.43M-11,360%$5.47M$39.49M+938%$11.91M-$2M-113%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Mirum Pharmaceuticals, Inc. generate?
Mirum Pharmaceuticals, Inc. (MIRM) generated -$171.0M in operating cash flow over the trailing twelve months.
What is Mirum Pharmaceuticals, Inc.'s free cash flow?
After $1.6M of capital expenditures, Mirum Pharmaceuticals, Inc.'s free cash flow was -$172.6M over the trailing twelve months, down 45270.7% year over year.
Where does Mirum Pharmaceuticals, Inc.'s cash flow data come from?
Every line is extracted from Mirum Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.